CXCR2 inhibition in NASH-HCC

Nat Rev Gastroenterol Hepatol. 2022 Jul;19(7):415. doi: 10.1038/s41575-022-00637-3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Hepatocellular*
  • Humans
  • Liver Neoplasms*
  • Non-alcoholic Fatty Liver Disease* / drug therapy